NCT04853030View on ClinicalTrials.gov

Fast Advanced Closed-Loop Therapy

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 6, 2021

Primary Completion Date

September 16, 2021

Study Completion Date

September 20, 2021

Conditions
Type 1 Diabetes
Interventions
DRUG

Fiasp

Advanced closed-loop insulin therapy with Faster acting insulin Aspart (Fiasp)

DRUG

Novorapid

Advanced closed-loop insulin therapy with Standard acting insulin Aspart (Novorapid

Trial Locations (2)

1000

UMC Ljubljana University Children's Hospital Ljubljana, Ljubljana

Unknown

Medical University of Graz Department of Pediatrics and Adolescent Medicine, Graz

All Listed Sponsors
collaborator

Medical University of Graz Department of Pediatrics and Adolescent Medicine, Graz, Austria

UNKNOWN

collaborator

UMC Ljubljana University Children's Hospital Ljubljana

UNKNOWN

lead

University of Ljubljana, Faculty of Medicine

OTHER

NCT04853030 - Fast Advanced Closed-Loop Therapy | Biotech Hunter | Biotech Hunter